Simplex Trading’s Agile Therapeutics AGRX Stock Holding History

Simplex Trading’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Hold	0	–	–	–	11546
2022 Q1	–	Sell	-6	Closed	-$3.83K	–	11765
2021 Q4	$5K	Sell	6 -4	-40%	-$5.64K	﹤0.01%	9611
2021 Q3	$26K	Hold	10	–	–	﹤0.01%	8216
2021 Q2	$26K	Buy	+10	New	+$33K	﹤0.01%	8358
2020 Q2	–	Sell	-4	Closed	-$20.8K	–	8618
2020 Q1	$13K	Sell	4 -4	-50%	-$23K	﹤0.01%	6315
2019 Q4	$39K	Buy	+8	New	+$27.9K	﹤0.01%	5433
2019 Q2	–	Sell	-1	Closed	-$2.79K	–	8037
2019 Q1	$1K	Buy	+1	New	+$2.12K	﹤0.01%	6970
2018 Q4	–	Hold	0	–	–	–	8075
2018 Q3	–	Sell	-18	Closed	-$13.2K	–	8286
2018 Q2	$17K	Buy	+18	New	+$63.2K	﹤0.01%	6000
2018 Q1	–	Hold	0	–	–	–	7100
2017 Q4	–	Sell	-1	Closed	-$9.31K	–	5722
2017 Q3	$4K	Buy	+1	New	+$7.68K	﹤0.01%	4647

Other funds holding AGRX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Simplex Trading's AGRX Position: Q2 2022 in Review

Simplex Trading held its Agile Therapeutics (AGRX) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #11546.

Simplex Trading first reported a position in AGRX in Q3 2017 and has held it in 8 quarters since. The position peaked at $39K in Q4 2019. 19 funds tracked by Wall St. Rank hold AGRX as of Q2 2022.

Simplex Trading held 0 shares of Agile Therapeutics worth $0 as of Q2 2022.
Simplex Trading left its Agile Therapeutics share count unchanged in Q2 2022.
Agile Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2022, its #11546 holding.
Simplex Trading first reported a position in Agile Therapeutics in Q3 2017 and has held it in 8 quarters since.
Simplex Trading's Agile Therapeutics position peaked at $39K in Q4 2019.
19 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.